Kwality Pharmaceuticals Ltd
₹3528.40
-89.90 (2.48%)
Sun, 25 Oct 2026, 04:56 pm
Health Technology
Pharmaceuticals: Major
24.5KKwality Pharmaceuticals Share Price Live Chart
1 Day
-89.90 (2.48%)
No Result Found
Summary
Market Cap (in Cr)
3664.56
Net Profit (in Cr)
67.35
P/B
4.10
Sector P/E
35.66
P/E
20.13
EV/EBITDA
12.33
Debt/Equity (Industry)
0.19
Interest Cover (Industry)
10.20
ROCE (Industry)
7.47
RONW (Industry)
6.26
ROE
22.67
ROCE
23.79
Debt/Equity
0.41
EPS (TTM)
78.68
Dividend Yield
0
Book Value
318.80
Interest Cover
9.16
Analysis
all
- Kwality Pharmaceuticals is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
- Kwality Pharmaceuticals is profitable, therefore cash runway is not a concern.
- Kwality Pharmaceuticals is profitable, therefore cash runway is not a concern.
- Debt is well covered by operating cash flow (63.2%, greater than 20% of total debt).
- Debt is covered by short term assets, assets are 3.9x debt.
- Unable to calculate sustainability of dividends as Kwality Pharmaceuticals has not reported any payouts.
- Unable to evaluate Kwality Pharmaceuticals's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
- Unable to evaluate Kwality Pharmaceuticals's dividend against the top 25% market benchmark as the company has not reported any payouts.
- The level of debt compared to net worth has increased over the past 5 years (37.4% vs 53% today).
- Kwality Pharmaceuticals's level of debt (53%) compared to net worth is high (greater than 40%).
Shareholding
| Shareholders | SEPT 2026 | JUN 2026 | MAR 2026 | DEC 2025 | SEPT 2025 |
|---|---|---|---|---|---|
| Promoters | 54.86 | 54.86 | 54.87 | 54.83 | 54.83 |
| FII | 2.50 | 3.13 | 2.79 | 0.50 | 0 |
| DII | 1.07 | 0.56 | 0.36 | 0.33 | 0.33 |
| Public | 41.57 | 41.44 | 41.98 | 44.34 | 44.84 |
| Government | 0 | 0 | 0 | 0 | 0 |
Technical Analysis
Support and Resistance
| Type | R3 | R2 | R1 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | 5012.68 | 4278.93 | 3957.57 | 3545.18 | 3223.82 | 2811.43 | 2077.68 |
| Fibonacci | 4278.93 | 3998.64 | 3825.48 | 3545.18 | 3264.89 | 3091.73 | 2811.43 |
| Camarilla | 3837.98 | 3770.72 | 3703.46 | 3545.18 | 3568.94 | 3501.68 | 3434.42 |
Pivots Level: Classic
R3
+1467.50
5012.68
R2
+733.75
4278.93
R1
+412.38
3957.57
S1
-321.37
3223.82
S2
-733.75
2811.43
S3
-1467.50
2077.68
Moving Average
Period
Value
10-EMA
3497.20
20-EMA
3513.15
30-EMA
3493.07
50-EMA
3387.77
100-EMA
3040.29
200-EMA
2490.32
Corporate Actions
| Announcement Date | Purpose | Action | Ex Date |
|---|---|---|---|
| 09 Aug 2026 | agm | ||
| 19 May 2026 | board-meetings | Accounts | |
| 12 Feb 2026 | board-meetings | Quarterly Results | |
| 13 Nov 2025 | board-meetings | Quarterly Results, Half Yearly Results | |
| 18 Aug 2025 | agm | ||
| 06 Sept 2024 | agm | ||
| 08 Sept 2023 | agm | ||
| 21 Sept 2022 | agm | ||
| 06 Sept 2021 | agm | ||
| 12 Sept 2017 | bonus | Bonus issue 1:1 | 12 Oct 2017 |
Peer Comparison
Kwality Pharmaceuticals Ltd
Divis Laboratories Ltd
Cipla Ltd
Sun Pharmaceutical Industries Ltd
Zydus Lifesciences Ltd
Torrent Pharmaceuticals Ltd
Kwality Pharmaceuticals Ltd About
Kwality Pharmaceuticals is engaged in the business of manufacturers, buyers and sellers of and dealers in all kind of drugs intermediates, chemicals, extracts, alkaloids and other pharmaceutical goods, toilet requisites, medicines, beverages and other medical preparations.
Industry
Pharmaceuticals - Indian - Bulk Drugs & Formln
Founded
1983
Headquarters
CEO
Employees
Contact
Website
http://www.kwalitypharma.com
cs@kwalitypharma.com
Phone
91-183-2774321-25
Location
Village Nagkalan, Majitha Road, Amritsar, Punjab, 143601
Kwality Pharmaceuticals Ltd Company History
| Year | History |
|---|---|
| 2014 |
|
| 2015 |
|
| 2016 |
|
| 2017 |
|
| 2024 |
|
Deals
| Client Name | Deal Type | Order Side | QTY | Avg Price | Date |
|---|---|---|---|---|---|
| ARK GLOBAL EMERGING COMPANIES, LP | bulk | Buy | 76400 | 1130.04 | 09 Jan 2026 |
| DEEPAK BANSAL | bulk | Sell | 69353 | 1122.42 | 09 Jan 2026 |
| AKNM SUPPLIERS PRIVATE LIMITED | bulk | Sell | 137152 | 316.41 | 10 Jul 2023 |
| AKNM SUPPLIERS PRIVATE LIMITED | bulk | Sell | 150000 | 295.1 | 03 Jul 2023 |
| BLUEPEAK CONSULTANCY LLP | bulk | Buy | 75000 | 295 | 03 Jul 2023 |
| AKNM SUPPLIERS PRIVATE LIMITED | bulk | Sell | 104000 | 295.38 | 30 Jun 2023 |
| AKNM SUPPLIERS PRIVATE LIMITED | bulk | Sell | 158564 | 294.07 | 26 Jun 2023 |
| AKNM SUPPLIERS PRIVATE LIMITED | bulk | Sell | 100000 | 295.49 | 08 Jun 2023 |
| AKNM SUPPLIERS PRIVATE LIMITED | bulk | Sell | 100000 | 295.19 | 05 Jun 2023 |
| AKNM SUPPLIERS PRIVATE LIMITED | bulk | Sell | 250000 | 344.24 | 19 Jan 2023 |
Frequently Asked Questions
1.What is the stock price of Kwality Pharmaceuticals Ltd?
As of 25/10/2026 at 10:26 PM, Kwality Pharmaceuticals Ltd shares are trading at ₹3528.40.
2.What is the market cap. of Kwality Pharmaceuticals Ltd?
As of 25/10/2026, the market capitalization of Kwality Pharmaceuticals Ltd is ₹3,664.56 crore.
3.When was Kwality Pharmaceuticals Ltd founded?
Kwality Pharmaceuticals Ltd was founded in 1983.
4.What are the P/E and P/B ratios of Kwality Pharmaceuticals Ltd?
As of 25/10/2026, Kwality Pharmaceuticals Ltd has a P/E ratio of 45.17 and a P/B ratio of 4.10.
5.How can I buy shares of Kwality Pharmaceuticals Ltd?
You can buy shares of Kwality Pharmaceuticals Ltd through Pocketful. Simply open a Demat account, complete your KYC, add funds, and place a buy order.
6.What is the shareholding pattern of Kwality Pharmaceuticals Ltd?
As of September,2026, promoters hold 54.86% in Kwality Pharmaceuticals Ltd, while FIIs, DIIs and public shareholders hold 2.50%, 1.07% and 41.57%, respectively.
7.Does Kwality Pharmaceuticals Ltd pay dividends?
No, Kwality Pharmaceuticals Ltd does not pay dividends to eligible shareholders currently.
8.What are the latest financial results of Kwality Pharmaceuticals Ltd?
For the financial year ended March 2025, Kwality Pharmaceuticals Ltd reported revenue of ₹370.00 crore and a net profit of ₹39.85 crore.
